Diethylnorspermine

DB06445InvestigationalSmall molecule

Investigated for use/treatment in renal cell carcinoma, pancreatic cancer, melanoma, and lung cancer.

Chemical structure of Diethylnorspermine
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in renal cell carcinoma, pancreatic cancer, melanoma, and lung cancer.Curator reviewed
Formula / weight
C13H32N4 · 244.427 g/mol (avg)
Also known as
1,3-PROPANEDIAMINE, N,N'-BIS(3-(ETHYLAMINO)PROPYL)- · DENSPM · N(1),N(11)-Diethylnorspermine · N1,N11-Diethylnorspermine
Code names
BE-333 · DE-333

Resolves to

Compound
UNIIHLI827Z1STCAS121749-39-1ChEMBLCHEMBL44083
Structure
InChIKeyUMJJGDUYVQCBMC-UHFFFAOYSA-NSMILESCCNCCCNCCCNCCCNCC
Targets
P21673SAT1

What you can answer from here — as of July 03, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
667Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Diethylnorspermine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In